Acute respiratory distress syndrome (ARDS) was first described in 1967, and since then
there have been a large number of studies addressing its pathogenesis and therapies …

Acute lung injury and acute respiratory distress syndrome (ARDS) are characterised by
severe hypoxemic respiratory failure and poor lung compliance. Despite advances in clinical …

Background: Multiple pharmacologic treatments have been studied for patients with acute
respiratory distress syndrome (ARDS) and acute lung injury (ALI). Our objective was to …

The importance of pulmonary surfactant in maintaining normal lung function, and the
observations that alterations in endogenous surfactant contribute to the lung dysfunction …

Over 50 years have passed since the acute respiratory distress syndrome (ARDS) was first
described. 1 Despite the passage of more than one-half of a century, almost all of ARDS …

Previously thought to be an uncommon disease, a recent epidemiologic study found the
incidence of acute lung injury (ALI) in the United States to be almost 1 per 1000 person …

Regardless of the cause, a common pathophysiological feature of patients with acute
respiratory distress syndrome is a dysfunction of the endogenous surfactant system …

Introduction: The acute respiratory distress syndrome (ARDS) is a common and catastrophic
condition, with a high mortality rate and economic burden on society. Despite 50 years of …

ARDS is a severe lung disease characterized by a very complex pathophysiology, involving
not only the respiratory system but also nonpulmonary distal organs. Elucidation of the …

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are a complex
response of the lung to direct or indirect insults, characterized by sudden-onset severe …